Salient Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-8,690
| Closed | -$650K | – | 147 |
|
|
2017
Q2 | $650K | Sell |
8,690
-2,578
| -23% | -$193K | 0.01% | 138 |
|
|
2017
Q1 | $750K | Sell |
11,268
-597
| -5% | -$39.7K | 0.01% | 150 |
|
|
2016
Q4 | $774K | Sell |
11,865
-56
| -0.5% | -$3.65K | 0.01% | 140 |
|
|
2016
Q3 | $843K | Buy |
11,921
+318
| +3% | +$22.5K | 0.02% | 124 |
|
|
2016
Q2 | $858K | Sell |
11,603
-2,597
| -18% | -$192K | 0.02% | 131 |
|
|
2016
Q1 | $922K | Sell |
14,200
-676
| -5% | -$43.9K | 0.03% | 128 |
|
|
2015
Q4 | $1.15M | Sell |
14,876
-10,736
| -42% | -$828K | 0.03% | 115 |
|
|
2015
Q3 | $2.11M | Sell |
25,612
-4,547
| -15% | -$375K | 0.05% | 96 |
|
|
2015
Q2 | $2.66M | Buy |
30,159
+1,690
| +6% | +$149K | 0.05% | 101 |
|
|
2015
Q1 | $2.52M | Sell |
28,469
-219
| -0.8% | -$19.4K | 0.05% | 97 |
|
|
2014
Q4 | $2.38M | Buy |
28,688
+1,887
| +7% | +$157K | 0.05% | 99 |
|
|
2014
Q3 | $2.26M | Buy |
26,801
+4,169
| +18% | +$352K | 0.04% | 111 |
|
|
2014
Q2 | $1.84M | Buy |
22,632
+3,060
| +16% | +$248K | 0.04% | 110 |
|
|
2014
Q1 | $1.49M | Buy |
19,572
+12,249
| +167% | +$933K | 0.04% | 114 |
|
|
2013
Q4 | $528K | Buy |
7,323
+2,132
| +41% | +$154K | 0.02% | 153 |
|
|
2013
Q3 | $357K | Sell |
5,191
-506
| -9% | -$34.8K | 0.01% | 137 |
|
|
2013
Q2 | $361K | Buy |
+5,697
| New | +$361K | 0.02% | 135 |
|